Back

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

28 August 2016 (13:15 - 13:32)
Organised by:
Congress Presentation Part of: Young Investigators Awards Session Thrombosis Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Christina Fanola

Brigham and Women's Hospital, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
PDK1 determines collagen-dependent platelet activation and is critical to development of arterial thrombosis and ischemic stroke in vivo
Doctor O. Borst (Tuebingen, DE)
Abstract Slides Video
Presentation thumbnail
Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study
Doctor L. Staerk (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Clinical impact and course of major bleeding events in patients with venous thromboembolism, treated with factor Xa inhibitors or vitamin K antagonists: an individual patient data analysis
Ms M. Brekelmans (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigators Awards Session Thrombosis

The Event

Event poster

ESC Congress 2016

28 August 2016 13:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources